Non-Clear Cell Renal Cell Carcinoma (nccRCC)

4 clinical trials · Condition

Record	Firm	Date
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors (NCT05176483)	Exelixis	2021-12-14
A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease (NCT02915783)	Eisai Inc.	2017-02-20

Every clearance here is in the API, with alerts when new ones post.